Advanced Enzyme Technologies Limited

BSE: ADVENZYMES540025ISIN INE837H01020

Healthcare
Biotechnology
BSE 1000

Share price

₹278.70+5.40 (+1.98%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹419.80
52W low: ₹247.10
Off 52W high: -33.61%
1M return: +2.18%
3M return: -16.17%
6M return: -21.63%
1Y return: -11.17%
20D avg volume: 12,268
50 DMA: ₹280.95
200 DMA: ₹308.79

Key ratios Consolidated

Market cap: ₹3,121 Cr
Current price: ₹278.70
52W high / low: ₹419.80 / ₹247.10
Face value: ₹2.00
P/E: 17.39
P/B: 1.85
EPS (TTM): ₹16.03
Book value / share: ₹150.98
ROE: —
ROCE: 13.60%
Operating margin: —
Net margin: —
Debt / equity: 0.01
Net debt: ₹-88.22 Cr
Interest cover: 89.42
Dividend yield: 0.48%
Dividend / share (TTM): ₹1.35
Payout: 8.42%
Cash conversion cycle: 138.2 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	214.51	189.79	203.37	171.95	184.53	185.91	167.18	169.11	146.09	154.52	157.81	160.94
	8.72	13.02	7.23	8.47	10.28	8.85	8.74	7.68	9.62	6.99	9.50	14.40
	223.23	202.81	210.59	180.42	194.81	194.76	175.92	176.80	155.71	161.52	167.31	175.33
	154.47	149.28	150.90	133.37	135.27	139.86	132.46	123.78	113.50	112.84	112.57	116.45
	59.09	54.50	55.96	45.64	48.74	43.97	45.94	36.76	39.05	40.20	35.90	44.00
	0.01	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—
	40.45	44.55	41.94	41.26	39.37	39.71	36.84	34.52	35.52	34.66	32.48	32.12
	1.18	0.58	0.57	0.57	0.72	0.76	0.81	0.94	0.93	0.87	0.85	0.68
	10.90	9.88	10.19	10.21	10.08	9.62	10.08	8.97	8.89	8.61	9.28	8.60
	45.53	44.58	41.27	39.93	40.53	39.72	38.65	40.50	35.46	34.45	34.45	39.98
	68.76	53.53	59.69	47.05	59.54	54.90	43.46	53.02	42.21	48.67	54.74	58.88
	0.00	0.00	0.11	11.25	0.00	0.00	0.00	0.00	0.00	0.00	-15.13	0.00
	68.76	53.53	59.80	58.29	59.54	54.90	43.46	53.02	42.21	48.67	39.61	58.88
	17.59	14.94	14.55	15.11	14.81	14.46	16.73	14.14	8.82	13.70	9.74	16.38
	51.15	38.59	45.25	43.18	44.73	40.44	26.73	38.88	33.39	34.98	29.87	42.50
	4.33	3.31	3.84	3.80	3.87	3.57	2.37	3.36	2.94	3.05	2.53	3.74
Key metrics
	80.84	63.99	70.56	69.07	70.34	65.28	54.35	62.93	52.03	58.15	49.74	68.16
	37.70%	33.70%	34.70%	40.20%	38.10%	35.10%	32.50%	37.20%	35.60%	37.60%	31.50%	42.40%
	23.80%	20.30%	22.30%	25.10%	24.20%	21.80%	16.00%	23.00%	22.90%	22.60%	18.90%	26.40%
	3.90%	—	3.50%	—	3.80%	—	2.90%	—	—	—	—	—
	16.20%	2.10%	21.60%	1.70%	26.30%	20.30%	5.90%	5.10%	—	—	—	—
	14.40%	-4.60%	69.30%	11.10%	34.00%	15.60%	-10.50%	-8.50%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	779.62	745.76	636.91	623.87	540.64	529.38
	37.44	34.83	33.04	36.66	25.46	6.42
	817.05	780.59	669.95	660.53	566.09	535.80
	588.02	559.41	482.59	457.58	421.64	364.75
	215.19	194.31	161.96	155.45	127.51	130.26
	0.01	0.00	0.00	0.02	0.02	0.07
	168.20	162.29	141.54	128.37	114.80	103.96
	2.90	2.63	3.56	2.93	2.42	1.80
	41.18	40.09	36.56	35.24	35.03	34.98
	171.31	161.45	149.07	146.46	137.59	114.29
	229.03	221.18	187.36	202.95	144.45	171.06
	11.36	11.36	0.00	-15.13	-4.06	0.00
	240.38	232.54	187.36	187.82	140.39	171.06
	62.19	58.93	53.39	50.87	36.52	47.26
	178.17	173.61	133.97	136.95	103.87	123.80
	15.28	15.08	11.72	11.92	9.45	10.70
Key metrics
	284.46	275.26	227.48	225.99	177.84	207.84
	36.49%	36.90%	35.70%	36.20%	32.90%	39.30%
	22.85%	23.30%	21.00%	22.00%	19.20%	23.40%
	—	13.60%	12.50%	—	—	—
	10.31%	17.10%	2.10%	15.40%	2.10%	—
	18.17%	29.60%	-2.20%	31.80%	-16.10%	—
	—	104.55	108.69	—	—	—
	—	0.90	1.06	—	—	—
	—	0.01	0.01	—	—	—
	—	-88.22	-72.69	—	—	—
	—	138.2	146.4	—	—	—
Balance sheet
	—	1,839	1,621	—	—	—
	—	1,044	879.87	—	—	—
	—	108.75	94.22	—	—	—
	—	145.02	115.40	—	—	—
	—	177.28	157.31	—	—	—
	—	—	11.07	—	—	—
	—	275.83	292.94	—	—	—
	—	39.96	17.20	—	—	—
	—	106.72	96.75	—	—	—
	—	20.53	21.53	—	—	—
	—	12.64	12.35	—	—	—
	—	7.89	9.18	—	—	—
	—	1,683	1,469	—	—	—
Cash flow
	—	156.78	142.50	—	—	—
	—	-74.13	-89.10	—	—	—
	—	-70.37	-72.54	—	—	—
	—	52.23	33.81	—	—	—

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	137.17	115.86	116.41	95.58	115.75	125.02	87.21	100.87	77.38	85.96	92.40	91.14
	16.40	2.29	5.16	1.29	3.08	53.85	4.53	1.43	1.66	53.88	3.21	3.56
	153.56	118.14	121.57	96.88	118.83	178.88	91.74	102.30	79.03	139.83	95.61	94.71
	102.45	88.40	92.73	75.20	89.21	97.48	76.23	81.76	66.71	67.68	66.27	69.35
	56.60	48.09	50.13	37.36	48.32	51.90	37.79	36.26	37.17	37.58	33.45	38.16
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—
	15.79	17.69	16.36	16.10	16.06	16.21	14.56	13.34	13.95	14.19	12.93	12.68
	0.03	0.04	0.06	0.04	0.05	0.05	0.08	0.06	0.08	0.02	0.05	0.04
	3.17	2.92	3.12	3.04	3.00	2.93	3.11	2.89	2.78	2.62	3.07	2.71
	28.12	26.16	24.59	22.30	24.04	22.04	20.29	21.86	20.80	19.42	18.73	20.33
	51.11	29.74	28.84	21.67	29.62	81.40	15.51	20.54	12.32	72.16	29.34	25.36
	0.00	0.00	0.00	-3.86	0.00	0.00	0.00	—	—	—	-18.95	—
	51.11	29.74	28.84	17.82	29.62	81.40	15.51	20.54	12.32	72.16	10.39	25.36
	9.41	7.39	6.55	4.57	7.34	7.42	4.46	5.36	3.19	5.10	7.25	6.24
	41.70	22.35	22.30	13.25	22.28	73.98	11.05	15.18	9.13	67.06	3.14	19.12
	3.74	2.00	1.99	1.18	1.99	6.61	0.99	1.36	0.82	6.00	0.28	1.71
Key metrics
	54.31	32.70	32.02	20.90	32.67	84.38	18.70	23.49	15.18	74.80	13.51	28.11
	39.60%	28.20%	27.50%	21.90%	28.20%	67.50%	21.40%	23.30%	19.60%	87.00%	14.60%	30.80%
	30.40%	19.30%	19.20%	13.90%	19.20%	59.20%	12.70%	15.00%	11.80%	78.00%	3.40%	21.00%
	7.10%	—	4.00%	—	4.30%	—	2.40%	—	—	—	—	—
	18.50%	-7.30%	33.50%	-5.20%	49.60%	45.40%	-5.60%	10.70%	—	—	—	—
	87.20%	-69.80%	101.80%	-12.70%	144.00%	10.30%	251.90%	-20.60%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	465.02	452.77	351.41	365.47	311.53	272.80
	25.14	63.39	61.49	58.81	9.81	9.08
	490.15	516.15	412.90	424.28	321.34	281.88
	358.78	354.62	292.37	271.34	247.06	209.81
	192.18	187.72	148.80	139.56	121.43	112.72
	0.00	0.00	0.00	—	—	—
	65.94	64.73	56.03	49.97	41.42	39.32
	0.17	0.21	0.24	0.16	0.14	0.10
	12.25	12.08	11.40	10.90	10.28	9.56
	101.17	92.97	82.36	78.58	72.31	61.63
	131.36	161.53	120.53	152.94	74.28	72.07
	-3.86	-3.86	0.00	-18.95	—	—
	127.51	157.67	120.53	133.99	74.28	72.07
	27.92	25.87	18.11	25.87	18.75	17.56
	99.60	131.81	102.42	108.12	55.53	54.51
	8.91	11.78	9.16	9.67	4.97	4.88
Key metrics
	139.93	169.96	132.17	145.05	84.70	81.73
	30.09%	37.50%	37.60%	39.70%	27.20%	30.00%
	21.42%	29.10%	29.10%	29.60%	17.80%	20.00%
	—	21.80%	18.80%	—	—	—
	8.43%	28.80%	-3.80%	17.30%	14.20%	—
	-18.69%	28.70%	-5.30%	94.70%	1.90%	—
	—	44.49	41.14	—	—	—
	—	0.67	0.62	—	—	—
	—	0.00	0.00	—	—	—
	—	-1.89	-5.60	—	—	—
	—	128.6	163.0	—	—	—
Balance sheet
	—	803.64	688.63	—	—	—
	—	315.98	232.20	—	—	—
	—	1.89	5.60	—	—	—
	—	94.32	78.17	—	—	—
	—	116.52	101.45	—	—	—
	—	5.38	5.19	—	—	—
	—	145.47	150.88	—	—	—
	—	51.19	22.68	—	—	—
	—	77.84	44.70	—	—	—
	—	0.00	0.00	—	—	—
	—	0.00	0.00	—	—	—
	—	0.00	0.00	—	—	—
	—	709.62	629.34	—	—	—
Cash flow
	—	88.73	63.48	—	—	—
	—	-34.19	-1.74	—	—	—
	—	-58.25	-57.63	—	—	—
	—	44.24	22.34	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +13.27%
Sales CAGR 5Y: —
Profit CAGR 3Y: +33.40%
Profit CAGR 5Y: —
Sales YoY (TTM): +8.43%
Profit YoY (TTM): -18.69%

Consolidated

Sales CAGR 3Y: +11.32%
Sales CAGR 5Y: —
Profit CAGR 3Y: +18.68%
Profit CAGR 5Y: —
Sales YoY (TTM): +10.31%
Profit YoY (TTM): +18.17%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 43.56%

Quarter	September 2026	June 2026
Promoter %	43.56%	43.24%

Holder	Type	Holding	Previous	Change
Vasant Rathi	Promoter	26.87%	26.68%	+0.19%
Orbimed Asia III Mauritius FVCI Limited	Public	12.15%	12.06%	+0.09%
Nalanda India Equity Fund Limited	Public	8.38%	8.45%	-0.07%
Vasant and Prabha Rathi Generation Trust	Promoter Group	6.75%	6.70%	+0.05%
Polunin Emerging Markets Small Cap Fund, LLC	Public	2.48%	2.46%	+0.02%
Rasika Vasant Rathi	Promoter Group	2.40%	2.38%	+0.02%
Rachana Vasant Rathi	Promoter Group	2.38%	2.36%	+0.02%
Reshma Namita Rathi	Promoter Group	2.38%	2.36%	+0.02%
Marval Guru Fund	Public	1.80%	1.79%	+0.01%
Pradip Bhailal Shah	Public	1.67%	1.66%	+0.01%
Mukund Madhusudan Kabra	Public	1.64%	1.63%	+0.01%
Kishor Laxminarayan Rathi HUF	Promoter Group	0.99%	0.98%	+0.01%
Prabhavati Vasant Rathi	Promoter Group	0.82%	0.82%	0.00%
Madhusudan Kabra	Promoter Group	0.55%	0.55%	0.00%
Kishor Laxminarayan Rathi	Promoter Group	0.37%	0.36%	+0.01%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Anthem Biosciences Limited	50,022	887.45	81.45	26.80%	—	—	+26.33%
Advanced Enzyme Technologies Limited	3,121	278.70	17.39	13.60%	+10.31% TTM	+18.17% TTM	-11.17%
Ennature Bio Pharma Limited	584	261.25	—	—	—	—	—
CCME GLOBAL LIMITED S	163	35.93	-189.11	-1.80%	—	-124.71% TTM	-78.98%
Vivo Bio tech Ltd.	31	13.88	-10.78	7.20%	+12.33% TTM	-133.73% TTM	-56.96%
Shree Ganesh Biotech (India) Limited S	18	0.44	-44.00	0.80%	-77.47% TTM	-400.00% TTM	-39.73%
GENOMIC VALLEY BIOTECH LIMITED S	17	55.67	-5,567.00	1.00%	-80.30% TTM	-110.00% TTM	+56.46%

Filings & corporate actions

Recent announcements

Please find enclosed herewith the intimation regarding the audio recording of the conference call held on November 03, 2026.3 Nov 2026 · Company Update / Analyst / Investor Meet
Intimation for submission of application to Stock Exchanges for Reclassification from Promoter Group to Public Category pursuant to Regulation 31A of the Securities and Exchange Board of ....3 Nov 2026 · Others
Please find enclosed herewith newspaper publication with respect to the unaudited financial results of the Company for the quarter and six months ended September 30, 2026.2 Nov 2026 · Company Update / Newspaper Publication
Please find enclosed herewith Post Buyback Public Announcement.31 Oct 2026 · Company Update / Post Buyback Public Announcement
Please find enclosed herewith Earnings Presentation for quarter and half year ended September 30, 2026.31 Oct 2026 · Company Update / Investor Presentation
Please find enclosed herewith press release titled Quarterly Earnings Release dated October 31, 2026.31 Oct 2026 · Company Update / Press Release / Media Release
The Board of Directors at their meeting held today i.e. October 31, 2026 have analysed the request received from the Promoter Group members for their reclassification from promoter group ....31 Oct 2026 · Others
Advanced enzyme Technologies Limited has informed the exchange about the unaudited financial results (Standalone and Consolidated) of the Company for the quarter and half year ended September ....31 Oct 2026 · Result / Financial Results
With reference to the notice of the Board Meeting dated October 23, 2026, we hereby inform that the Board of Directors at its meeting held on October 31, 2026 has approved the Unaudited ....31 Oct 2026 · Board Meeting / Outcome of Board Meeting
Closure of Buyback30 Oct 2026 · Company Update / Closure of Buy Back
Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 30, 202630 Oct 2026 · Corp Action / Daily Buy Back of equity shares
Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 29, 202629 Oct 2026 · Corp Action / Daily Buy Back of equity shares
Daily Report pursuant to Regulations 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 28, 202628 Oct 2026 · Corp Action / Daily Buy Back of equity shares
Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 27, 202627 Oct 2026 · Corp Action / Daily Buy Back of equity shares
Conference call for Analysts and Investors to discuss the un-audited financial results of the Company for the quarter and half year ended September 30, 2026 on Tuesday, November 03, 2026 ....26 Oct 2026 · Company Update / Analyst / Investor Meet
Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 26, 202626 Oct 2026 · Corp Action / Daily Buy Back of equity shares
Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 23, 202623 Oct 2026 · Corp Action / Daily Buy Back of equity shares
Advanced Enzyme Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2026 ,inter alia, to consider and approve the Un-Audited ....23 Oct 2026 · Board Meeting / Board Meeting
Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 22, 202622 Oct 2026 · Corp Action / Daily Buy Back of equity shares
Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 21, 202621 Oct 2026 · Corp Action / Daily Buy Back of equity shares
Intimation of receipt of request from Promoter Group Member for reclassification from Promoter Group Category to Public Category Shareholders under Regulation 31A of the SEBI (Listing Obligations ....20 Oct 2026 · Others
Intimation of receipt of request from Promoter Group Member for reclassification from Promoter Group Category to Public Category Shareholders under Regulation 31A of the SEBI (Listing Obligations ....19 Oct 2026 · Others
Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 19, 202619 Oct 2026 · Corp Action / Daily Buy Back of equity shares
Daily Report pursuant to Regulation 18(i) of the Buyback Regulation regarding the Equity Shares bought back on October 16, 202616 Oct 2026 · Corp Action / Daily Buy Back of equity shares
Intimation of receipt of request from few Promoter Group Members for reclassification from Promoter Group category to Public Category Shareholders under Regulation 31A of the SEBI (Listing ....15 Oct 2026 · Others
Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 15, 202615 Oct 2026 · Corp Action / Daily Buy Back of equity shares
Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 14, 2026.14 Oct 2026 · Corp Action / Daily Buy Back of equity shares
Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 13, 202613 Oct 2026 · Corp Action / Daily Buy Back of equity shares
Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 12, 2026.12 Oct 2026 · Corp Action / Daily Buy Back of equity shares
Please find enclosed herewith the intimation of receipt of request from few promoter group members for reclassification from Promoter Group Category to Public Category under Regulation ....12 Oct 2026 · Company Update / General
Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 09, 20269 Oct 2026 · Corp Action / Daily Buy Back of equity shares
Please find enclosed herewith Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended September ....9 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 08, 20268 Oct 2026 · Corp Action / Daily Buy Back of equity shares
Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 07, 20267 Oct 2026 · Corp Action / Daily Buy Back of equity shares
Extinguishment of 8,88,296 (Eight Lakh Eighty Eight Thousand Two Hundred and Ninety Six) fully paid-up Equity Shares of the face value of Rs. 2/- each (Rupees Two Only) of Advanced Enzyme ....7 Oct 2026 · Company Update / Buy back
Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 06, 20266 Oct 2026 · Corp Action / Daily Buy Back of equity shares
Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 05, 20265 Oct 2026 · Corp Action / Daily Buy Back of equity shares
Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on October 01, 20261 Oct 2026 · Corp Action / Daily Buy Back of equity shares
Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on September 30, 202630 Sep 2026 · Corp Action / Daily Buy Back of equity shares
Intimation of receipt of revised request from the Promoter Group Member requesting the reclassification from the Promoter Group Category to the Public Category of Shareholders of the Company ....29 Sep 2026 · Company Update / General

Corporate actions

Purpose	Ex date	Record date	Payment date
Dividend - Rs. - 1.3500	24 Jul 2026	24 Jul 2026	—
Final Dividend - Rs. - 1.2000	23 Jul 2025	23 Jul 2025	—
Interim Dividend - Rs. - 4.0000	16 May 2025	17 May 2025	—
Final Dividend - Rs. - 1.1000	18 Jul 2024	18 Jul 2024	—

Board meetings

31 Oct 2026 Board Meeting - Financial Results
8 Aug 2026 Board Meeting - Financial Results